Jozef Stefan Institute
Study suggests cysteine cathepsins offer cancer treatment opportunities
Published in Lab Business Week, August 22nd, 2004
"Cysteine cathepsins are involved in degradation of extracellular matrix, facilitating growth, invasion, and metastasis of tumor cells, in tumor angiogenesis, in apoptosis, and in events of inflammatory and immune responses," wrote researchers from the Jozef Stefan Institute in Ljubljana.
"In this issue of Cancer Cell [we] demonstrate [the] association of increased cathepsins activity with angiogenic vasculature and invasive fronts of carcinomas during tumorigenesis in transgenic mouse models using activity-based chemical probes and in vivo imaging,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-08-22)
More Articles from Lab Business Week
- 305/575-6043
Pharmaceutical company reports record results for second quarter of 2004 - ATS Medical, Inc.
Heart valve maker reports 78% second quarter revenue growth - Advanced Magnetics, Inc.
Pharmaceutical company reports quarterly loss of $0.10 per share - Aeolus Pharmaceuticals, Inc.
Pharmaceutical company's new name, trading symbol are effective - Affymetrix, Inc.
GeneChip maker reports income of $0.12 per share - American Oriental Bioengineering
Biotech firm expects double-digit revenue, net income growth for 2Q - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
